These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1990530

  • 1. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T, Sayegh MH, Kut JP, Hancock WW, Milford EL, Tilney NL, Kupiec-Weglinski JW.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract] [Full Text] [Related]

  • 2. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
    Hancock WW, Sablinski T, Milford EL, Tilney NL, Atkins RC, Kupiec-Weglinski JW.
    Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Sablinski T, Hancock WW, Mix CT, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract] [Full Text] [Related]

  • 4. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
    Sablinski T, Hancock WW, Schmidbauer G, Milford EL, Kupiec-Weglinski JW.
    Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
    [No Abstract] [Full Text] [Related]

  • 5. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H, Hara MH, Miyahara T, Tanigawa M, Matsuzaki Y, Onitsuka T, Shibata K, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Iwaya M, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract] [Full Text] [Related]

  • 6. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1994 Jul 15; 58(1):80-6. PubMed ID: 8036712
    [Abstract] [Full Text] [Related]

  • 7. Specific unresponsiveness in rats with prolonged allograft survival is dependent upon the graft and suppressor T cells.
    Hall BM, Gurley K, Dorsch SE.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 1):495-6. PubMed ID: 2978915
    [No Abstract] [Full Text] [Related]

  • 8. The effect of combined treatment with total lymphoid irradiation, cyclosporin A, and anti-CD4 monoclonal antibodies in a hamster-to-rat heart transplantation model.
    Steinbrüchel DA, Madsen HH, Nielsen B, Kemp E, Larsen S, Koch C.
    Transplant Proc; 1991 Feb 15; 23(1 Pt 1):579-80. PubMed ID: 1990614
    [No Abstract] [Full Text] [Related]

  • 9. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH, Hancock WW, Colby AJ, Padberg W, Diamantstein T, Kupiec-Weglinski JW, Tilney NL.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep 15; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 11. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T, Hara Y, Imanishi M, Kanda H, Kurita T.
    Transplant Proc; 1993 Dec 15; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract] [Full Text] [Related]

  • 12. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 13. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K, Lehmann M, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    Transplant Proc; 1997 May 01; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract] [Full Text] [Related]

  • 14. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y, Matsuura T, Imanishi M, Tahara H, Kurita T.
    Transplant Proc; 1994 Dec 01; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract] [Full Text] [Related]

  • 15. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA, Lillevang ST, Nielsen B, Kemp E.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract] [Full Text] [Related]

  • 16. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME, Tchervenkov JI, Alexander JW, Cofer BR.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract] [Full Text] [Related]

  • 17. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 18. W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients.
    Padberg WM, Kupiec-Weglinski JW, Lord RH, Towpik E, Tilney NL.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):493-4. PubMed ID: 3274813
    [No Abstract] [Full Text] [Related]

  • 19. Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells.
    Choti M, Lenrow D, Roza A, Markmann J, Naji A.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 1):478-9. PubMed ID: 2565055
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin 2 receptor in rat allograft rejection.
    Bouchot O, Anegon I, Romaniuk A, Jacques Y, Soulillou JP.
    Transplant Proc; 1990 Aug 01; 22(4):1995-7. PubMed ID: 2202134
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.